| Absorption |
| Blood-Brain Barrier | BBB- | 0.9065 |
| Human Intestinal Absorption | HIA+ | 0.9813 |
| Caco-2 Permeability | Caco2- | 0.7345 |
| P-glycoprotein Substrate | Substrate | 0.5342 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8319 |
| Non-inhibitor | 0.9528 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8984 |
| Distribution |
| Subcellular localization | Lysosome | 0.6633 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.6509 |
| CYP450 2D6 Substrate | Non-substrate | 0.8389 |
| CYP450 3A4 Substrate | Non-substrate | 0.6286 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5918 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8940 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9193 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9234 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8798 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8471 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9560 |
| Non-inhibitor | 0.9293 |
| AMES Toxicity | Non AMES toxic | 0.8948 |
| Carcinogens | Non-carcinogens | 0.7688 |
| Fish Toxicity | High FHMT | 0.7559 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8591 |
| Honey Bee Toxicity | Low HBT | 0.7810 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | IV | 0.6234 |
| Carcinogenicity (Three-class) | Non-required | 0.6252 |